Name | 2-imidazol-1-ylacetic acid |
---|---|
Synonyms |
imidazol-1-ylacetic acid
(1-Imidazolyl)acetic Acid MFCD01721800 1-carboxymethylimidazole 2-(1H-Imidazol-1-yl)acetic acid 1H-Imidazole-1-acetic acid 1-Imidazoleacetic Acid T5N CNJ A1VQ imidazolyl acetic acid 1-(Carboxymethyl)imidazole Imidazol-1-yl-acetic acid imidazole-1-acetic acid imidazoleacetic acid 1H-Imidazol-1-ylacetic acid |
Description | Imidazol-1-yl-acetic acid is an endogenous metabolite. |
---|---|
Related Catalog |
Density | 1.3±0.1 g/cm3 |
---|---|
Boiling Point | 392.1±25.0 °C at 760 mmHg |
Melting Point | 257-260 ºC |
Molecular Formula | C5H6N2O2 |
Molecular Weight | 126.113 |
Flash Point | 190.9±23.2 °C |
Exact Mass | 126.042931 |
PSA | 55.12000 |
LogP | -0.57 |
Vapour Pressure | 0.0±1.0 mmHg at 25°C |
Index of Refraction | 1.588 |
Storage condition | Refrigerator |
Symbol |
GHS05, GHS07 |
---|---|
Signal Word | Danger |
Hazard Statements | H315-H318-H335 |
Precautionary Statements | P280-P305 + P351 + P338 + P310 |
Hazard Codes | Xi:Irritant |
Risk Phrases | R36/37/38 |
Safety Phrases | 26-39 |
RIDADR | NONH for all modes of transport |
HS Code | 2933290090 |
~94% 22884-10-2 |
Literature: O'Neill, Brian Thomas; Nagel, Arthur Adam; Humphrey, John Michael; Sobolov-Jaynes, Susan Beth; Chappie, Thomas Allen; Vincent, Lawrence Albert; Arnold, Eric Platt; Huang, Jianhua Patent: US2003/87925 A1, 2003 ; US 20030087925 A1 |
~% 22884-10-2 |
Literature: WO2005/66188 A1, ; Page/Page column 9 ; |
~85% 22884-10-2 |
Literature: ALBEMARLE CORPORATION Patent: WO2007/109542 A2, 2007 ; Location in patent: Page/Page column 4; 6 ; |
~% 22884-10-2 |
Literature: WO2005/63717 A1, ; Page/Page column 5 ; |
~30% 22884-10-2 |
Literature: ISIS Pharmaceuticals, Inc. Patent: US5886177 A1, 1999 ; |
~% 22884-10-2 |
Literature: Journal of the Chemical Society, , p. 1806,1809 |
~% 22884-10-2 |
Literature: Chemical and Pharmaceutical Bulletin, , vol. 31, # 4 p. 1213 - 1221 |
Precursor 9 | |
---|---|
DownStream 1 | |
HS Code | 2933290090 |
---|---|
Summary | 2933290090. other compounds containing an unfused imidazole ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |